Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia
2022 · Journal of Hematology & Oncology · 110 citations
https://doi.org/10.1186/s13045-022-01376-3
M
Matilde Sinibaldi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
90
Papers
1.7K
Citations
19
h-index
23
i10-index
Matilde Sinibaldi is an academic researcher from Bambino Gesù Children's Hospital. The author has contributed to research in topics: CAR-T cell therapy research & Virus-based gene therapy research & Immunotherapy and Immune Responses. The author has an h-index of 19, co-authored 77 publications.
ORCID: 0000-0001-5277-8998Papers by this author
worksCD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T-cells
2020 · Haematologica · 69 citations
https://doi.org/10.3324/haematol.2019.231183
Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies
2023 · Nature Communications · 54 citations
https://doi.org/10.1038/s41467-023-38723-y
Data from GD2-Targeting CAR T-cell Therapy for Patients with GD2<sup>+</sup> Medulloblastoma
2024 · 0 citations
https://doi.org/10.1158/1078-0432.c.7265758.v1
Supplemental Figure 14 from GD2-Targeting CAR T-cell Therapy for Patients with GD2<sup>+</sup> Medulloblastoma
2024 · 0 citations
https://doi.org/10.1158/1078-0432.25956307.v1
Supplemental Figure 17 from GD2-Targeting CAR T-cell Therapy for Patients with GD2<sup>+</sup> Medulloblastoma
2024 · 0 citations
https://doi.org/10.1158/1078-0432.25956295
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat